Preparation and Quality Control of 99mTc-Calciumgluconate

B. Zmbova; D. Djokić; V. Jovanović; I. Tadžer; T. Memedović

doi:10.1055/s-0038-1623797

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 1983; 22(03): 166-168
DOI: 10.1055/s-0038-1623797

Originalarbeiten - Original Articles

Schattauer GmbH

Preparation and Quality Control of ^99mTc-Calciumgluconate

Darstellung und Kontrolle der Qualität des ^99mTc-Kalziumglukonats

Authors

B. Zmbova

¹From the Boris Kidric Institute of Nuclear Sciences, Vinca, Beograd, University of Skoplje, Yugoslavia
D. Djokić

¹From the Boris Kidric Institute of Nuclear Sciences, Vinca, Beograd, University of Skoplje, Yugoslavia
V. Jovanović

¹From the Boris Kidric Institute of Nuclear Sciences, Vinca, Beograd, University of Skoplje, Yugoslavia
I. Tadžer

^*Institute of Pathophysiology, University of Skoplje, Yugoslavia
T. Memedović

¹From the Boris Kidric Institute of Nuclear Sciences, Vinca, Beograd, University of Skoplje, Yugoslavia

Abstract

A procedure for the labelling of lyophilised Sn-Ca-Gluconate by a ^99mTc instant technique was developed. Paper and TLC chromatography and low-voltage electrophoresis were used for the determination of the labelling yield which reached between 95 to 98%. The biodistribution was followed in white (albino) rats. About 25 to 35% of the total activity of the compound was retained in the kidneys one hour after its i.v. injection.

Es wurde eine Methode zur Markierung von lyophilisiertem Sn-Ca-Glukonat unter Anwendung der ^99mTc-SofortTechnik entwickelt. Sowohl Papierund Dünnschichtchromatographie als auch Tiefspannungselektrophorese wurden für die Bestimmung der Markierungsausbeute verwendet, die zwischen 95-98% erreichte. Die Bioverteilung wurde an weißen Ratten untersucht. Etwa 25-35% der Gesamtaktivität des Präparats werden eine Stunde nach dessen intravenöser Injektion in den Nieren zurückgehalten.

Full Text

References

References
1 Arnold RW, Subramanian G, McAfee JG. et al. Comparison of ^99mTc complexes for renal imaging. J. nucl. Med 16: 357-367 1975;
2 Boyd RE, Robson J, Hunt EC. et al. ^99mTc gluconate complexes for renal scintigraphy. Brit. J. Radiol 46: 604-612 1973;
3 Lin TH, Khentigan A, Winchell HS. A ^99mTc-chelate substitute for organoradiomercurial renal agents. J. nucl. Med 15: 34-35 1974;
4 Machida T, Miki M, Ueda M. et al. Basic studies of various ^99mTc-labelled renal agents and clinical application of ^99mTcmalate. Nukl. Med 16: 36-41 1975;
5 Rajs J, Ahlberg NE, Orrenius S. et al. Accumulation of ^99mTc-gluconate in isolated rat cardiac myocytes and hepatocytes during anoxia. Act. Radiol. Oncol 18: 218-224 1979;